NJGK(600064)2025-04-22 09:50Financial Performance - In 2024, the company achieved a net profit attributable to shareholders of CNY 1,725,229,897.01, an increase of 10.58% compared to CNY 1,560,145,875.01 in 2023[6]. - The company's operating revenue for 2024 was CNY 1,975,445,403.11, representing a decrease of 58.21% from CNY 4,726,511,629.41 in 2023[22]. - The net profit attributable to the parent company was CNY 1,725.23 million, reflecting a year-on-year growth of 10.58%[32]. - The company achieved a basic earnings per share of CNY 0.997 in 2024, representing a 10.53% increase compared to CNY 0.902 in 2023[23]. - The company reported a weighted average return on equity of 9.47%, an increase of 0.29 percentage points from 9.18% in the previous year[23]. - The net profit attributable to the listed company, excluding non-recurring gains and losses, for 2024 is approximately ¥1.62 billion, a decrease of 1.54% compared to ¥1.65 billion in 2023[194]. Cash Flow and Assets - The net cash flow from operating activities was negative CNY 500,820,614.84, an improvement from negative CNY 2,177,480,214.41 in the previous year[22]. - The total assets at the end of 2024 were CNY 38,395,047,667.66, a 2.98% increase from CNY 37,283,181,671.10 at the end of 2023[22]. - The company's asset-liability ratio at the end of the reporting period was 47.97%, with interest-bearing liabilities totaling 9.5 billion yuan, accounting for 24.74% of total assets[36]. - The current ratio improved slightly to 1.17 in 2024 from 1.16 in 2023, while the quick ratio decreased by 5.38% to 0.39[194]. - The debt-to-asset ratio decreased to 47.97% in 2024 from 50.24% in 2023, reflecting a reduction of 4.50%[194]. Dividends and Retained Earnings - The company plans to distribute a cash dividend of CNY 3 per 10 shares, totaling CNY 519,101,893.20, subject to shareholder approval[6]. - The retained earnings available for distribution to shareholders for 2024 amounted to CNY 12,791,290,611.56 after accounting for previous year’s dividends[6]. - The cash dividend for the fiscal year 2023 represents 30.09% of the net profit attributable to ordinary shareholders, which is approximately 1.73 billion RMB[134]. - The cumulative cash dividends over the last three fiscal years amount to approximately 1.73 billion RMB, with an average cash dividend payout ratio of 91.27%[136]. Business Segments and Revenue Sources - The real estate business recorded a contract sales area of 18,700 square meters, a significant decrease of 92.66% year-on-year[33]. - The contract sales amount for the real estate sector was CNY 620.31 million, down 67.59% compared to the previous year[33]. - The municipal business generated revenue of CNY 1,153.73 million, a decrease of 5.67% year-on-year[34]. - The revenue from the pharmaceutical sales segment reached CNY 264,427,648.89, marking a new addition to the company's revenue streams[49]. - The company's main revenue sources for 2024 included real estate development sales, generating approximately ¥197.54 million[200]. Investment and Future Plans - The company plans to gradually exit the real estate business over the next 3-5 years, focusing on high-tech industry investments[35]. - The company invested in three new projects in the high-tech sector, including DiNuoWeiHua and RuiChu Pharmaceutical[35]. - The company aims to strengthen its core business in equity investment and develop the biopharmaceutical industry as a main transformation direction[89]. - The company plans to enhance project sales and cash flow management in its real estate business while gradually exiting real estate development[90]. Risk Management - The company has identified various risks including macroeconomic, business development, investment management, and financial risks in its future outlook[9]. - The company has been actively managing risks for eight consecutive years, with a focus on risk prevention and resolution, particularly in light of macroeconomic conditions and industry trends[96]. - The company’s future plans and strategies are subject to investment risks and do not constitute a commitment to investors[7]. Environmental and Social Responsibility - The company has invested approximately 34.09 million RMB in environmental protection during the reporting period[141]. - The new wastewater treatment plant has a designed processing capacity of 60,000 tons per day, with pollutant discharge limits set at COD ≤ 766.5 tons/year and ammonia nitrogen ≤ 61.32 tons/year, with no exceedances reported during the reporting period[144]. - The company has committed to social responsibility, with a total investment of 8.01 million yuan in public welfare projects, including support for new employment groups[151]. Management and Governance - The total pre-tax remuneration for the board members and senior management during the reporting period amounted to 686.19 million CNY[105]. - The company has established a performance assessment and remuneration management implementation method for the years 2023-2025[113]. - The company has implemented a comprehensive governance structure, enhancing compliance and operational transparency to protect shareholder rights and promote sustainable development[100]. - The company has a diverse management team with backgrounds in finance, engineering, and economics, enhancing its strategic capabilities[106]. Shareholder Information - The total number of common shareholders as of the end of the reporting period is 45,355, an increase from 43,574 at the end of the previous month[171]. - The largest shareholder, Nanjing New Port Development Co., Ltd., holds 601,083,220 shares, representing 34.74% of the total shares, with 229,000,000 shares frozen[173]. - The company has not engaged in any share buybacks during the reporting period[182].